Scarica l'app Stockscreener
5.43
1.27%
-0.07
Dopo l'orario di chiusura:
5.51
0.08
+1.47%
Cytek Biosciences Inc Borsa (CTKB) Ultime notizie
Is Cytek Biosciences Inc. stock attractive for retirement portfoliosRisk Management & Technical Confirmation Trade Alerts - ulpravda.ru
What analyst consensus implies for Cytek Biosciences Inc. (8EQ) stockBond Market & Weekly High Return Forecasts - ulpravda.ru
Why Cytek Biosciences Inc. stock is a must watch in 2025Earnings Miss & High Yield Equity Trading Tips - ulpravda.ru
CTKB FinancialsIncome Statement - Quiver Quantitative
Will Cytek Biosciences Inc. (8EQ) stock top growth indexesRate Cut & AI Driven Price Predictions - ulpravda.ru
User | bentoncourier.comCytek Biosciences, Inc.Common Stock (Nasdaq:CTKB) Stock Quote - FinancialContent
Is Cytek Biosciences (NASDAQ:CTKB) Using Debt In A Risky Way? - 富途牛牛
2026 world cup standings odds: How currency fluctuations impact Cytek Biosciences Inc. stock2026 world cup usa national team round of 16 playmakers transition play match prediction analysis - ulpravda.ru
Cytek Biosciences Inc 8EQ Stock Analysis and ForecastCandlestick Pattern Analysis & Affordable Portfolio Strategies - earlytimes.in
What risks investors should watch in Cytek Biosciences Inc stockGap Down & Free Safe Capital Growth Stock Tips - moha.gov.vn
How currency fluctuations impact Cytek Biosciences Inc. stockStock Screening Results & Big Data Market Reports - bollywoodhelpline.com
Why Cytek Biosciences Inc. (8EQ) stock attracts HNW investorsTrading Psychology Tips & Small Entry Cost Trading - bollywoodhelpline.com
What dividend safety score for Cytek Biosciences Inc. stockLong-Term Investment Plans & Fast Profit Trading Strategies - bollywoodhelpline.com
Cytek Biosciences webinar explores lung cell communication advances - Traders Union
Cytek Biosciences Data Breach Investigation - Claim Depot
Cytek Biosciences Data Breach Exposes Social Security Numbers - Claim Depot
Book value per share of Cytek Biosciences, Inc. – DUS:8EQ - TradingView — Track All Markets
How Cytek Biosciences Inc. stock responds to policy changes2025 Trading Volume Trends & Accurate Buy Signal Alerts - Улправда
Pharma News: How Cytek Biosciences Inc. stock responds to policy changesJuly 2025 Sector Moves & Expert-Curated Trade Recommendations - Улправда
Is Cytek Biosciences Inc. (8EQ) stock a buy on weakness2025 EndofYear Setup & Safe Capital Preservation Plans - DonanımHaber
Is Cytek Biosciences Inc. (8EQ) stock at risk of policy regulationTrade Ideas & High Accuracy Trade Signal Alerts - DonanımHaber
Cytek Biosciences Earnings Notes - Trefis
Cytek Biosciences, Inc. (NASDAQ:CTKB) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
Cytek BioSciences Inc (CTKB) expanding its growth trajectory ahead - Setenews
Why Cytek Biosciences Inc. (8EQ) stock stays on buy listsQuarterly Portfolio Report & High Accuracy Buy Signal Tips - Newser
Institutional Owners May Consider Drastic Measures as Cytek Biosciences, Inc.'s (NASDAQ:CTKB) Recent US$58m Drop Adds to Long-term Losses - 富途牛牛
Brown Capital Management LLC Has $24.17 Million Stock Position in Cytek Biosciences, Inc. $CTKB - MarketBeat
Is Cytek Biosciences Inc. stock overvalued by current metricsJuly 2025 EndofMonth & Precise Entry and Exit Recommendations - Newser
Can Cytek Biosciences Inc. stock beat market expectations this quarter - Newser
Can Cytek Biosciences Inc. (8EQ) stock sustain revenue momentumGDP Growth & Safe Capital Growth Plans - Newser
Why Cytek Biosciences Inc. stock attracts global investorsWeekly Trend Report & Fast Gain Stock Tips - Newser
Can Cytek Biosciences Inc. stock maintain operating marginsEarnings Growth Summary & Entry Point Strategy Guides - Newser
Is Cytek Biosciences Inc. (8EQ) stock attractive for dividend growthJuly 2025 Sentiment & Community Verified Trade Alerts - Newser
What is Cytek BioSciences Inc (CTKB) Stock Return on Shareholders’ Capital? - setenews.com
Tranche Update on Cytek Biosciences, Inc.'s Equity Buyback Plan announced on December 30, 2024. - marketscreener.com
Will Cytek Biosciences Inc. (8EQ) stock draw ESG focused funds2025 Fundamental Recap & AI Driven Stock Price Forecasts - Newser
Morgan Stanley Raises Price Target on Cytek Biosciences to $6 From $4, Keeps Equalweight Rating - marketscreener.com
Cytek Biosciences (CTKB) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Published on: 2025-12-02 04:27:45 - Newser
Check out these key findings about Cytek BioSciences Inc (CTKB) - Setenews
Cytek Biosciences, Inc. (NASDAQ:CTKB) Receives Average Rating of "Hold" from Brokerages - MarketBeat
2.10%
0.57%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):